Purpose of the development: For the treatment of bone lesions (osteoporosis, the initial stages of deforming arthrosis) treatment of hepatitis of various etiologies, and may also be used as a hepatoprotective in complex chemotherapy for cancer.

Recommended application field: Medicine. For patients with bone lesions, such as osteoporosis, osalgii, the initial stages of deforming osteoarthritis, patients with hepatitis of various etiologies.

Advantages over analogues: The drug is not a hormonal drug, it is made up of natural substances.

The development stage readiness: Pre-production model is made

Description of the development:
()
The drug has a high physiological activity, well tolerated easily and rapidly metabolized by the body in large quantities, a positive effect on: the organic and mineral components of bone anabolic processes, bone regeneration, the adhesive-platelet aggregation enhances antibacterial defense by granulocytes blood has disintoxicational effect, prevent blood vessels bleed, does not cause allergic reactions, elimination of osteoporosis and anemia. Medical prophylactic agent of the complex action "KOREKTIN" was examined by the State Ministry of Health of Ukraine Farmtsentra. The permission of the State Ministry of Health of Ukraine Farmtsentru clinical trials of the drug.

Information about newness of the development:
there are Ukrainian patents -- 1 items

corresponds technical description
Ready for implementation

Possibility of transfer abroad:
Licence's sale
Licence's sale
Technological document's sale
Combinated reduction to industrial level

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua